Evidence map›Paper›PMID 28397100›Full record

ArticleEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2017

The burden and epidemiology of community-acquired central nervous system infections: a multinational study.

H Erdem, A Inan, E Guven, S Hargreaves, L Larsen, G Shehata, E Pernicova, E Khan, L Bastakova, S Namani and 65 more

Abstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Managing penicillin resistant pneumococcal meningitis: an international id-iri study.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2025
    Article
  7. The Neurohospitalist · 2025
    Article
  8. Article
  9. CEST MRI in the Management/Diagnosis of Neuroinfectious Diseases.International journal of molecular sciences · 2025
    Review
  10. Article
  11. Article
  12. Understanding the mechanisms ofTissue barriers · 2025
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. The MetaGens algorithm for metagenomic database lossy compression and subject alignment.Database : the journal of biological databases and curation · 2023
    Article
  19. Review
  20. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

75 authors.

H ErdemPrincipal Coordinator of ID-IRI, Ankara, Turkey. hakanerdem1969@yahoo.com.
A InanDepartment of Infectious Diseases and Clinical Microbiology, Haydarpasa Numune Training and Research Hospital, Istanbul, Turkey.
E GuvenBeytepe Murat Erdi Eker State Hospital, Ankara, Turkey.
S HargreavesInternational Health Unit, Section of Infectious Diseases and Immunity, Commonwealth Building, Hammersmith Campus, Imperial College London, London, UK.
L LarsenDepartment of Infectious Diseases Q, Odense University Hospital, Odense, Denmark.
G ShehataDepartment of Neurology and Psychiatry, Assiut University Hospital, Assiut, Egypt.
E PernicovaAvenier, Centres for Vaccination and Travel Medicine, Prague, Czech Republic.
E KhanShifa International Hospital, Islamabad, Pakistan.
L BastakovaFaculty Hospital Brno, Department of Infectious Diseases and Masaryk University Faculty of Medicine, Brno, Czech Republic.
S NamaniInfectious Diseases Clinic, University Clinical Center of Kosovo, Prishtina, Kosovo.
A HarxhiService of Infectious Disease, University Hospital Center of Tirana, Tirana, Albania.
T RoganovicInfectious Diseases Clinic, University Hospital Clinical Center Banja Luka, Banja Luka, Bosnia and Herzegovina.
B LakatosDepartment of Infectious Diseases, Saint Laszlo Hospital, Budapest, Hungary.
S UysalDepartment of Infectious Diseases and Clinical Microbiology, Seyfi Demirsoy State Hospital, Buca, İzmir, Turkey.
O R SipahiDepartment of Infectious Diseases and Clinical Microbiology, Ege University School of Medicine, Izmir, Turkey.
A CrisanDepartment of Infectious Diseases, Victor Babes University of Medicine and Pharmacy, Timisoara, Romania.
E MiftodeHospital of Infectious Diseases, Gr. T. Popa University of Medicine and Pharmacy, Iasi, Romania.
R StebelFaculty Hospital Brno, Department of Infectious Diseases and Masaryk University Faculty of Medicine, Brno, Czech Republic.
B JegorovicClinic for Infectious and Tropical Diseases, Clinical Centre of Serbia, Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
Z FehérDepartment of Infectious Diseases, Markusovszky University Teaching Hospital, Szombathely, Hungary.
C JekkelDepartment of Infectious Diseases, Saint Laszlo Hospital, Budapest, Hungary.
N PandakGeneral Hospital Slavonski Brod, Department for Infectious Diseases, School of Medicine, University of Split, Split, Croatia.
A MoravvejiSocial Determinants of Health Research Center, Department of Community Medicine, Kashan University of Medical Sciences, Kashan, Iran.
H YilmazDepartment of Infectious Diseases and Clinical Microbiology, Ondokuz Mayis University School of Medicine, Samsun, Turkey.
A KhalifaDepartment of Neurology, Damascus Hospital, Damascus, Syria.
U MusabakDepartment of Immunology and Allergy, Losante Hospital, Ankara, Turkey.
S YilmazGulhane Medical Academy, Blood Bank, Clinical Microbiology Division, Ankara, Turkey.
A JouharDepartment of Neurology, Damascus Hospital, Damascus, Syria.
N OztoprakAntalya Education and Research Hospital, Antalya, Turkey.
X ArgemiInfectious Diseases Department, Nouvel Hôpital Civil, Strasbourg, France.
M BaldeyrouInfectious Diseases Department, Nouvel Hôpital Civil, Strasbourg, France.
G BellaudDepartment of Infectious Diseases, Tenon University Hospital, Paris, France.
R V MorotiCarol Davila University of Medicine and Pharmacy and Matei Bals National Institute for Infectious Diseases, Bucharest, Romania.
R HasbunMedical School, Department of Infectious Diseases, The University of Texas Health Science Center at Houston, Houston, TX, USA.
L SalazarMedical School, Department of Infectious Diseases, The University of Texas Health Science Center at Houston, Houston, TX, USA.
R TekinDepartment of Infectious Diseases and Clinical Microbiology, Dicle University School of Medicine, Diyarbakir, Turkey.
A CanestriDepartment of Infectious Diseases, Tenon University Hospital, Paris, France.
L ČalkićDepartment of Infectious Diseases, Zenica Cantonal Hospital, Zenica, Bosnia and Herzegovina.
L PraticòUniversity Division of Infectious and Tropical Diseases, Piazza Spedali Civili, 25123, Brescia, Italy.
F Yilmaz-KaradagGoztepe Training and Research Hospital, Department of Infectious Diseases and Clinical Microbiology, Medeniyet University, Istanbul, Turkey.
L SantosInfectious Diseases Service, Centro Hospitalar São João and Faculty of Medicine, University of Porto, Porto, Portugal.
A PintoInfectious Diseases Service, Centro Hospitalar São João and Faculty of Medicine, University of Porto, Porto, Portugal.
F KaptanDepartment of Infectious Diseases and Clinical Microbiology, Katip Celebi University School of Medicine, Izmir, Turkey.
P BossiDepartment Maladies Infectieuses, Institut Pasteur de Paris-HPA, Paris, France.
J AronDepartment Maladies Infectieuses, Institut Pasteur de Paris-HPA, Paris, France.
A DuissenovaDepartment of Infectious and Tropical Diseases, Asfendiyarov Kazakh National Medical University, Almaty, Kazakhstan.
G ShopayevaDepartment of Infectious and Tropical Diseases, Asfendiyarov Kazakh National Medical University, Almaty, Kazakhstan.
B UtaganovDepartment of Infectious and Tropical Diseases, Asfendiyarov Kazakh National Medical University, Almaty, Kazakhstan.
S GrgicClinic for Infectious Diseases, University Hospital of Mostar, Mostar, Bosnia and Herzegovina.
G ErsozDepartment of Infectious Diseases and Clinical Microbiology, Mersin University School of Medicine, Mersin, Turkey.
A K L WuDepartment of Clinical Pathology, Pamela Youde Nethersole Eastern Hospital, Hong Kong SAR, China.
K C LungDepartment of Clinical Pathology, Pamela Youde Nethersole Eastern Hospital, Hong Kong SAR, China.
A BruzsaDepartment of Infectious Diseases, Saint Laszlo Hospital, Budapest, Hungary.
L B RadicDepartment of Infectious Diseases, General Hospital Dubrovnik, Dubrovnik, Croatia.
H KahramanDepartment of Infectious Diseases and Clinical Microbiology, Ege University School of Medicine, Izmir, Turkey.
M Momen-HeraviDepartment of Infectious Diseases, Social Determinants of Health Research Center, Kashan University of Medical Sciences, Kashan, Iran.
S KulzhanovaDepartment of Infectious Diseases, Astana Medical University, Astana, Kazakhstan.
F RigoUnit of Infectious Diseases, Azienda Ospedaliera Universitaria Integrata, Verona, Italy.
M KonkayevaDepartment of Infectious Diseases, Astana Medical University, Astana, Kazakhstan.
Z SmagulovaDepartment of Infectious Diseases, Astana Medical University, Astana, Kazakhstan.
T TangInfectious Diseases Team, Department of Medicine, Queen Elizabeth Hospital, Hong Kong, China.
P ChanNeurology Team, Department of Medicine, Queen Elizabeth Hospital, Hong Kong, China.
S AhmetagicUniversity Clinical Center Tuzla, Tuzla, Bosnia and Herzegovina.
H Porobic-JahicUniversity Clinical Center Tuzla, Tuzla, Bosnia and Herzegovina.
F MoradiInfectious and Tropical Diseases Research Center, Hormozgan University of Medical Sciences, Bandar Abbas, Iran.
S KayaDepartment of Infectious Diseases and Clinical Microbiology, Karadeniz Technical University School of Medicine, Trabzon, Turkey.
Y CagSchool of Medicine, Department of Infectious Diseases and Clinical Microbiology, Medeniyet University, Istanbul, Turkey.
A BohrInstitute of Inflammation Research, Department of Infectious Diseases and Rheumatology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
C ArtukDepartment of Infectious Diseases and Clinical Microbiology, Gulhane Training and Research Hospital, Ankara, Turkey.
I CelikDepartment of Infectious Diseases and Clinical Microbiology, Kayseri Training and Research Hospital, Kayseri, Turkey.
M AmsilliInfectious Diseases Unit, CHU Bicètre, Paris, France.
H C GulDepartment of Infectious Diseases and Clinical Microbiology, Gulhane Training and Research Hospital, Ankara, Turkey.
A CascioDepartment of Health Promotion Sciences and Mother and Child Care "G. D'Alessandro", University of Palermo, Palermo, Italy.
M LanzafameUnit of Infectious Diseases, Azienda Ospedaliera Universitaria Integrata, Verona, Italy.
M NassarInfection Control Department, Saudi German Hospital Group, Jeddah, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Risk assessment of central nervous system (CNS) infection patients is of key importance in predicting likely pathogens. However, data are lacking on the epidemiology globally. We performed a multicenter study to understand the burden of community-acquired CNS (CA-CNS) infections between 2012 and 2014. A total of 2583 patients with CA-CNS infections were included from 37 referral centers in 20 countries. Of these, 477 (18.5%) patients survived with sequelae and 227 (8.8%) died, and 1879 (72.7%) patients were discharged with complete cure. The most frequent infecting pathogens in this study were Streptococcus pneumoniae (n = 206, 8%) and Mycobacterium tuberculosis (n = 152, 5.9%). Varicella zoster virus and Listeria were other common pathogens in the elderly. Although staphylococci and Listeria resulted in frequent infections in immunocompromised patients, cryptococci were leading pathogens in human immunodeficiency virus (HIV)-positive individuals. Among the patients with any proven etiology, 96 (8.9%) patients presented with clinical features of a chronic CNS disease. Neurosyphilis, neurobrucellosis, neuroborreliosis, and CNS tuberculosis had a predilection to present chronic courses. Listeria monocytogenes, Staphylococcus aureus, M. tuberculosis, and S. pneumoniae were the most fatal forms, while sequelae were significantly higher for herpes simplex virus type 1 (p < 0.05 for all). Tackling the high burden of CNS infections globally can only be achieved with effective pneumococcal immunization and strategies to eliminate tuberculosis, and more must be done to improve diagnostic capacity.

Indexed as

Population SurveillanceAdultAgedAged, 80 and overAge FactorsCentral Nervous System InfectionsCommunity-Acquired InfectionsCross-Sectional StudiesFemaleHumansMaleMiddle AgedOutcome Assessment, Health CareRetrospective StudiesYoung AdultAdverse Clinical OutcomeBrain AbscessCentral Nervous System DiseaseCentral Nervous System InfectionHuman Immunodeficiency Virus

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.